目的 研究人肝癌发生过程中p38MAPK和乙型肝炎病毒X蛋白(HBX)对细胞增殖和凋亡的影响,探讨肝癌发生的机制. 方法 应用免疫组织化学和DNA原位末端标记(TUNEL)法原位检测人肝癌(36例)和相关慢性肝病组织(慢性乙型肝炎、肝硬化和癌周肝硬化分别为20、20、36例)的p38MAPK、HBX、细胞周期G2/M期相关因子(cdc25B,p34cdc2,细胞周期蛋白B1)、细胞增殖因子Ki-67和细胞凋亡情况.根据资料不同分别采用x2检验、One-Way ANOVA或t检验进行统计学处理. 结果 HBX在慢性乙型肝炎(65.0%)和肝癌组(44.4%)阳性率较高,主要表达于胞核; p38MAPK、cdc25B、细胞周期蛋白B1、p34cdc2的阳性率从正常肝组织(40.0%,20.0%,20.0%,30.0%)、慢性乙型肝炎(60.0%,65.0%,40.0%,50.0%)、肝硬化(65.0%,75.0%,70.0%,55.0%)、癌周肝硬化(66.7%,75.0%,75.0%,63.9%)到肝癌组(77.8%,80.6%,80.6%,72.2%)逐渐增高,表达部位发生改变.p38MAPK胞核表达主要见于慢性乙型肝炎组和肝硬化组,胞质表达见于癌周肝硬化组和肝癌组,癌周肝硬化组与肝癌组之间的差异无统计学意义(x2=1.11,P>0.05).正常肝、慢性乙型肝炎、肝硬化、癌周肝硬化和肝癌组织中的增殖指数(0.0000±0.000,0.0502±0.011,0.0411±0.009,0.0762±0.017,0.1810±0.036)和凋亡指数(0.0351±0.024,0.0607±0.022,0.0562±0.013,0.0716±0.011,0.1200±0.018)比较,除肝硬化外也逐渐增高,增殖指数在肝癌分化差组(0.2285±0.062)高于分化好组(0.1216±0.032,t=2.082,P=0.044),凋亡指数肝癌在分化好组(0.152±0.026)高于分化差组(0.081±0.022,t=2.129,P=0.041).结论 肝癌发生过程中,HBX可能通过p38MAPK通路引起细胞周期、细胞增殖和凋亡的异常改变.细胞增殖基本与凋亡相伴随,肝癌增殖程度高于凋亡程度.癌周肝硬化不同于不伴癌的肝硬化,与肝癌的关系更密切.
目的 研究人肝癌髮生過程中p38MAPK和乙型肝炎病毒X蛋白(HBX)對細胞增殖和凋亡的影響,探討肝癌髮生的機製. 方法 應用免疫組織化學和DNA原位末耑標記(TUNEL)法原位檢測人肝癌(36例)和相關慢性肝病組織(慢性乙型肝炎、肝硬化和癌週肝硬化分彆為20、20、36例)的p38MAPK、HBX、細胞週期G2/M期相關因子(cdc25B,p34cdc2,細胞週期蛋白B1)、細胞增殖因子Ki-67和細胞凋亡情況.根據資料不同分彆採用x2檢驗、One-Way ANOVA或t檢驗進行統計學處理. 結果 HBX在慢性乙型肝炎(65.0%)和肝癌組(44.4%)暘性率較高,主要錶達于胞覈; p38MAPK、cdc25B、細胞週期蛋白B1、p34cdc2的暘性率從正常肝組織(40.0%,20.0%,20.0%,30.0%)、慢性乙型肝炎(60.0%,65.0%,40.0%,50.0%)、肝硬化(65.0%,75.0%,70.0%,55.0%)、癌週肝硬化(66.7%,75.0%,75.0%,63.9%)到肝癌組(77.8%,80.6%,80.6%,72.2%)逐漸增高,錶達部位髮生改變.p38MAPK胞覈錶達主要見于慢性乙型肝炎組和肝硬化組,胞質錶達見于癌週肝硬化組和肝癌組,癌週肝硬化組與肝癌組之間的差異無統計學意義(x2=1.11,P>0.05).正常肝、慢性乙型肝炎、肝硬化、癌週肝硬化和肝癌組織中的增殖指數(0.0000±0.000,0.0502±0.011,0.0411±0.009,0.0762±0.017,0.1810±0.036)和凋亡指數(0.0351±0.024,0.0607±0.022,0.0562±0.013,0.0716±0.011,0.1200±0.018)比較,除肝硬化外也逐漸增高,增殖指數在肝癌分化差組(0.2285±0.062)高于分化好組(0.1216±0.032,t=2.082,P=0.044),凋亡指數肝癌在分化好組(0.152±0.026)高于分化差組(0.081±0.022,t=2.129,P=0.041).結論 肝癌髮生過程中,HBX可能通過p38MAPK通路引起細胞週期、細胞增殖和凋亡的異常改變.細胞增殖基本與凋亡相伴隨,肝癌增殖程度高于凋亡程度.癌週肝硬化不同于不伴癌的肝硬化,與肝癌的關繫更密切.
목적 연구인간암발생과정중p38MAPK화을형간염병독X단백(HBX)대세포증식화조망적영향,탐토간암발생적궤제. 방법 응용면역조직화학화DNA원위말단표기(TUNEL)법원위검측인간암(36례)화상관만성간병조직(만성을형간염、간경화화암주간경화분별위20、20、36례)적p38MAPK、HBX、세포주기G2/M기상관인자(cdc25B,p34cdc2,세포주기단백B1)、세포증식인자Ki-67화세포조망정황.근거자료불동분별채용x2검험、One-Way ANOVA혹t검험진행통계학처리. 결과 HBX재만성을형간염(65.0%)화간암조(44.4%)양성솔교고,주요표체우포핵; p38MAPK、cdc25B、세포주기단백B1、p34cdc2적양성솔종정상간조직(40.0%,20.0%,20.0%,30.0%)、만성을형간염(60.0%,65.0%,40.0%,50.0%)、간경화(65.0%,75.0%,70.0%,55.0%)、암주간경화(66.7%,75.0%,75.0%,63.9%)도간암조(77.8%,80.6%,80.6%,72.2%)축점증고,표체부위발생개변.p38MAPK포핵표체주요견우만성을형간염조화간경화조,포질표체견우암주간경화조화간암조,암주간경화조여간암조지간적차이무통계학의의(x2=1.11,P>0.05).정상간、만성을형간염、간경화、암주간경화화간암조직중적증식지수(0.0000±0.000,0.0502±0.011,0.0411±0.009,0.0762±0.017,0.1810±0.036)화조망지수(0.0351±0.024,0.0607±0.022,0.0562±0.013,0.0716±0.011,0.1200±0.018)비교,제간경화외야축점증고,증식지수재간암분화차조(0.2285±0.062)고우분화호조(0.1216±0.032,t=2.082,P=0.044),조망지수간암재분화호조(0.152±0.026)고우분화차조(0.081±0.022,t=2.129,P=0.041).결론 간암발생과정중,HBX가능통과p38MAPK통로인기세포주기、세포증식화조망적이상개변.세포증식기본여조망상반수,간암증식정도고우조망정도.암주간경화불동우불반암적간경화,여간암적관계경밀절.
Objective To investigate the effects of host-derived p38 mitogen-activated protein kinase subunit 38 (p38MAPK) and the hepatitis B virus X antigen (HbxAg) on cell proliferation and apoptosis in human hepatocellular carcinoma (HCC),and to study the mechanism underlying hepatocarcinogenesis.Methods Liver tissues were biopsied from healthy individuals and patients with chronic hepatitis B (CHB),liver cirrhosis,paratumor cirrhosis,and HCC.Immunohistochemical staining was used to detect expressions of HBxAg,p38MAPK,cell cycle G2/M phase-related factors (cdc25B,p34cdc2,cyclin B1),and cell proliferation factor ki-67.The terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling method (known as TUNEL) was used to detect apoptosis.Results The highest rates of HBxAg were detected in CHB (65.0%) and HCC (44.4%) liver samples,and the antigen was mainly expressed in nuclei.Increasingly higher rates of p38MAPK,cdc25B,cyclin B1,and p34cdc2 expression were detected with increases in disease severity:normal liver (40.0%,20.0%,20.0%,and 30.0%,respectively),chronic hepatitis B (60.0%,65.0%,40.0%,and 50.0%,respectively),liver cirrhosis (65.0%,75.0%,70.0%,and 55.0%,respectively),paratumor cirrhosis (66.7%,75.0%,75.0%,and 63.9%,respestively),and HCC (77.8%,80.6%,80.6%,and 72.2%,respectively).In addition,the intracellular location of p38MAPK expression was different under different disease conditions,showing nuclear expression in CHB and liver cirrhosis samples and cytoplasmic expression in paratumor cirrhosis and HCC samples (x2 =1.11,P > 0.05).The proliferation index (PI) and the apoptosis index (AI) were both increased along with disease severity (nommal > CHB > paratumor cirrhosis > HCC) (PI:0.0000 ± 0.000,0.0502 ± 0.011,0.0411 ± 0.009,0.0762 ± 0.017; AI:0.0351 ± 0.024,0.0607 ±0.022,0.0562 ± 0.013,0.0716 ± 0.011),with the notable exception for liver cirrhosis (PI:0.1810 ± 0.036 and AI:0.1200 ± 0.018).PI in poorly-differentiated HCC (0.2285 ± 0.062) was significantly higher than in welldifferentiated HCC (0.1216 ± 0.032,t =2.082,P =0.044).AI in well-differentiated HCC (0.152 ± 0.026) was significantly higher than in poorly-differentiated HCC (0.081 ± 0.022,t =2.129,P =0.041).Conclusions In the process of hepatocarcinogenesis,HBxAg may cause a series of abnormal changes in cell cycle,proliferation and apoptosis by affecting the expression of p38MAPK.